Open Access

Expert Review of Vaccines

, volume 24 , issue 1 , pages 11-26

Readiness assessment for cervical cancer elimination and prevention of human papillomavirus (hpv)-related cancers in Europe – are we winning the RACE?

Eugenia Karamousouli ¹

Ugne Sabale ²

Stefano Valente ^{3, 4}

Fanut Morosan ^{5, 6}

Maria Heuser ^{7, 8}

Olivia Dodd ^{7, 8}

Danielle Riley ^{7, 8}

Louise Heron ^{7, 8}

Giovanna Elisa Calabrò ⁹

Theodoros Agorastos ^{10, 11}

Paul Sevelda ^{12, 13}

Zoárd Tibor Krasznai ^{14, 15}

Shay Nahum ^{16, 17}

Rune Horby ^{18, 19}

Hide authors affiliations Show authors affiliations: 19 affiliations

Regional Market Access, MSD, Athens, Greece |

Value & Implementation Outcomes Research, MSD, Vilnius, Lithuania |

Value & Implementation Global Medical and Scientific Affairs, MSD, Italy |

⁴

Value & Implementation Global Medical and Scientific Affairs, MSD, Rome, Italy |

⁵

Regional Market Access, MSD, Romania |

⁶

Regional Market Access, Regional Market Access, MSD, Bucharest, Romania |

⁷

Adelphi Values PROVE, UK |

⁸

Adelphi Values PROVE, Macclesfield, Cheshire, UK |

⁹

Department of Human, Social and Health Sciences, University of Cassino and Southern Lazio, Cassino, Italy |

¹⁰

ARISTOTLE UNIVERSITY OF THESSALONIKI, Greece |

¹¹

School of Health Sciences, Department of Medicine, Third Clinic of Obstetrics and Gyneacology, Aristotle University of Thessaloniki, Thessaloniki, Greece |

¹²

Austrian Cancer Aid, Vienna, Austria |

¹³

Karl Landsteiner Institute for gynecologic Oncology and Senology, Austrian Cancer Aid, Vienna, Austria |

¹⁴

Department of Obstetrics and Gynecology, University of Debrecen Faculty of Medicine, Hungary |

¹⁵

Department of Obstetrics and Gynecology, University of Debrecen Faculty of Medicine, Debrecen, Hungary |

¹⁶

Regional Market Access, MSD, Israel |

¹⁷

Regional Market Access, MSD, Aviel, Israel |

¹⁸

Public Policy Mid-European Region, MSD, Denmark |

¹⁹

Public Policy Mid-European Region, MSD, Copenhagen, Denmark |

Publication type: Journal Article

Publication date: 2024-12-15

Taylor & Francis

Expert Review of Vaccines

scimago Q1

wos Q2

SJR: 1.255

CiteScore: 11.2

Impact factor: 4.8

ISSN: 14760584, 17448395

DOI: 10.1080/14760584.2024.2438759

Copy DOI

PubMed ID: 39670677

Found

Top-30

Journals

	1
Journal of Medical Economics	Journal of Medical Economics, 1, 25% Journal of Medical Economics 1 publication, 25%
Healthcare	Healthcare, 1, 25% Healthcare 1 publication, 25%
Photodiagnosis and Photodynamic Therapy	Photodiagnosis and Photodynamic Therapy, 1, 25% Photodiagnosis and Photodynamic Therapy 1 publication, 25%
Frontiers in Public Health	Frontiers in Public Health, 1, 25% Frontiers in Public Health 1 publication, 25%
	1

Publishers

	1
Taylor & Francis	Taylor & Francis, 1, 25% Taylor & Francis 1 publication, 25%
MDPI	MDPI, 1, 25% MDPI 1 publication, 25%
Elsevier	Elsevier, 1, 25% Elsevier 1 publication, 25%
Frontiers Media S.A.	Frontiers Media S.A., 1, 25% Frontiers Media S.A. 1 publication, 25%
	1

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

PDF

Metrics

Cite this

GOST |

Cite this

GOST Copy

Karamousouli E. et al. Readiness assessment for cervical cancer elimination and prevention of human papillomavirus (hpv)-related cancers in Europe – are we winning the RACE? // Expert Review of Vaccines. 2024. Vol. 24. No. 1. pp. 11-26.

GOST all authors (up to 50) Copy

Karamousouli E., Sabale U., Valente S., Morosan F., Heuser M., Dodd O., Riley D., Heron L., Calabrò G. E., Agorastos T., Sevelda P., Krasznai Z. T., Nahum S., Horby R. Readiness assessment for cervical cancer elimination and prevention of human papillomavirus (hpv)-related cancers in Europe – are we winning the RACE? // Expert Review of Vaccines. 2024. Vol. 24. No. 1. pp. 11-26.

RIS |

Cite this